Promising clinical trials surrounding Retatrutide , specifically the 120 milligram formulation branded as ZPHC, reveal a significant impact on physique reduction and linked chronic factors. Experts posit that this dual agonist , affecting both GLP-1 and GIP pathways , may offer a noteworthy improvement in the treatment of overweight and connected